Vertex Pharmaceutical’s year-to-date stock performance.
Vertex Pharmaceuticals: “I think Vertex is very strong. I wish I had bought it for the Charitable Trust a long time ago when we had the CEO on. It was an excellent call, and then I got cold feet. That was a mistake. It’s a good buy.”
Oddity Tech’s year-to-date stock performance.
Oddity Tech: “Frankly, that industry…is just too hard. And that was my bad that I just didn’t realize how hard when we had them on the show. I thought they told a very good story, but the story did not pan out.”
ImmunityBio’s year-to-date stock performance.
ImmunityBio: “I’m going to tell you that it is not clear exactly what they did wrong, but they got in trouble. I got to see how they get out of trouble, and then we’ll take a hard look at it.”
Aehr Test Systems’ year-to-date stock performance.
Aehr Test Systems: “The stock has run too much. It went parabolic. We have to wait. I wish I didn’t have to say it, but we have to wait.”
Copart’s year-to-date stock performance.
Copart: “I want to buy that stock. It’s too cheap…I think you’re buying it right at the bottom.”
